Innovent Releases Results of a Phase 1 Clinical Study of IBI362, a Dual Glucagon-like Peptide-1 and Glucagon Receptor Agonist in Chinese Patients with Type 2 Diabetes at the International...
SAN FRANCISCO and SUZHOU, China, Dec. 7, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, announces that results of a phase 1 clinical trial of IBI362 (LY3305677), a dual glucagon-like petide-1 (GLP-1) and glucagon receptor agonist...
Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for a Novel Glucagon-Like Peptide-1 Analogue, GZR18
BEIJING and BRIDGEWATER, N.J., Dec. 7, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), is pleased to announce that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for the company's compound, GZR18, to improve the management of type 2 diabetes mellitus....
RaySearch receives large RayStation order in China for carbon ion treatment planning
RaySearch Laboratories AB (publ) announces a large order for the treatment planning system RayStation®* by Lanzhou Ion Therapy Co, LTD, a Chinese manufacturer of accelerator systems for carbon ion therapy STOCKHOLM, Dec. 7, 2021 /PRNewswire/ -- Carbon ion therapy is a highly advanced radiation therapy technique that can be effective for complex...
Moscow ranked first among European cities in the ranking of innovations against COVID-19
Moscow ranks third in the world, behind New York and San Francisco MOSCOW, Dec. 7, 2021 /PRNewswire/ -- Moscow is recognized as the first European city in the ranking of innovations, that are used for the formation of resilience to the coronavirus. It is ahead of London and Barcelona. The Russian capital ranks third among the world's megacities, behind San...
Updated NCCN Distress Thermometer and Problem List Helps People Cope with Cancer Symptoms and Treatment
Landmark tool for measuring the psycho-social impact of cancer gets an overhaul to reflect the latest research, helping patients receive better care by addressing their physical and emotional wellbeing. PLYMOUTH MEETING, Pa., Dec. 7, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network (NCCN®)—a nonprofit alliance of leading cancer centers—announces updates to its widely-used...
Happiness Development Exported $1.2 million Lucidum Products
NANPING, China, Dec. 7, 2021 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ: HAPP) a China-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce solutions, and the sales of automobile, announced today that it has signed sales of goods agreements with several trading companies to export its lucidum products with a total value...
Effort to reduce burden of disease in Australia shines spotlight on natural medicine to support liver health
SYDNEY, Dec. 7, 2021 /PRNewswire/ -- The prevalence of liver health issues is emerging as a serious cost and health burden for Australia with the spotlight on evidence-based natural ingredients that might help support liver health and possibly assist in reducing the burden of the disease. A new Victorian study published in the Medical Journal of Australia this year reveals...
Broncus enter into strategic partnership with New Frontier Health Corporation /United Family Healthcare
HANGZHOU, China, Dec. 6, 2021 /PRNewswire/ -- Broncus Holding Corporation (2216.HK) ("Broncus"), the leader of minimally invasive diagnostic and therapeutic technology for solutions to different lung diseases in China, today announced that it has entered into a strategic cooperation framework agreement with New Frontier Health Corporation, the operator of China's leading premium private healthcare service provider United Family Healthcare,...
Sustainable Superfoods: Sophie’s BioNutrients Aims to Replace Soy as a Commercially Viable Protein Alternative within 5 years
SINGAPORE, Dec. 6, 2021 /PRNewswire/ -- Sophie's Bionutrients, a next-generation sustainable urban food production technology company, is shaping the future of food with high moisture extrusion (HME) technology and microalgae fermentation. This process is a revolutionary development in the plant-based protein industry. It offers a commercially viable alternative to cell-based meat production...
RedHill Biopharma Reports that Opaganib Mechanism Not Impacted by Viral Spike-Protein Mutations, Including Omicron Mutations
Unique Mode of Action Opaganib works by targeting the human host cell rather than the virus itself and is therefore not expected to be impacted by spike protein mutations, providing a strong rationale for its potential to address the Omicron SARS-CoV-2 variant, as well as other variants of concern Regulatory update...
